The role of combination therapy in the management of hypertension

Nephrology Dialysis Transplantation

Volumn 21, Issue 6, 2006, Pages 1469-1473

  Neutel, Joel M ^a  

^a Orange County Research Center   (United States)

Author keywords

Angiotensin receptor blockers; Combination therapy; Goal blood pressure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; PLACEBO; THIAZIDE DIURETIC AGENT;

AFRICAN AMERICAN; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL PRACTICE; COUGHING; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOSE RESPONSE; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EDITORIAL; FATIGUE; HEADACHE; HUMAN; HYPERTENSION; IMPOTENCE; INSOMNIA; LIBIDO DISORDER; LOW DRUG DOSE; PATIENT CARE; PATIENT COMPLIANCE; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; RACE DIFFERENCE; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; DISEASE MANAGEMENT; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION;

EID: 33744801730     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk064     Document Type: Editorial

References (15)

1. Lewington S, Clarke R, Qizilbash N et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data from one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913
2. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001; 358: 1305-1315
3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 report. J Am Med Assoc 2003; 289: 2560-2574
4. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. J Am Med Assoc 2003; 290: 199-206
5. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-486
6. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762
7. Man in't Veld AJ. Clinical overview of irbesartan: Expanding the therapeutic window in hypertension. J Hypertens 1997; 15 [Suppl 7]: S27-S33
8. Frishman WH, Bryzinski BS, Coulson LR et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154: 1461-1468
9. McGill JB, Reilly PA. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension. Clin Cardiol 2001; 24: 66-72
10. Chrysant SG, Weber MA, Wang AC, Hinman DJ. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. Am J Hypertens 2004; 17: 252-259
11. Kochar M, Guthrie R, Triscari J et al. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension. Am J Hypertens 1999; 12: 797-805
12. Giles TD, Bakris GL, Smith DH et al. Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial. Am J Hypertens 2003; 16: 460-466
13. Kuschnir E, Acuna E, Sevilla D et al. Treatment of patients with essential hypertension: Amlodipine 5mg/benazepril 20 mg compared with amlodipine 5mg, benazepril 20mg, and placebo. Clin Ther 1996; 18: 1213-1224
14. Neutel JM, Saunder E, Bakris GL et al. The efficacy and safety of low- and high-dose fixed combination of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: The INCLUSIVE trial. J Clin Hypertens 2005; 7: 578-586
15. Mancia G, Omboni S, Grassi G. Combination treatment in hypertension: The VeraTran Study. Am J Hypertens 1997; 10: 153S-158S